175 related articles for article (PubMed ID: 16002945)
1. Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers.
Chiou HE; Liu CL; Buttrey MJ; Kuo HP; Liu HW; Kuo HT; Lu YT
Chest; 2005 Jul; 128(1):263-72. PubMed ID: 16002945
[TBL] [Abstract][Full Text] [Related]
2. Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.
Muller MP; Dresser L; Raboud J; McGeer A; Rea E; Richardson SE; Mazzulli T; Loeb M; Louie M;
Pharmacotherapy; 2007 Apr; 27(4):494-503. PubMed ID: 17381375
[TBL] [Abstract][Full Text] [Related]
3. Severe acute respiratory syndrome: clinical outcome and prognostic correlates.
Tsui PT; Kwok ML; Yuen H; Lai ST
Emerg Infect Dis; 2003 Sep; 9(9):1064-9. PubMed ID: 14519241
[TBL] [Abstract][Full Text] [Related]
4. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada.
Knowles SR; Phillips EJ; Dresser L; Matukas L
Clin Infect Dis; 2003 Oct; 37(8):1139-42. PubMed ID: 14523782
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.
Booth CM; Matukas LM; Tomlinson GA; Rachlis AR; Rose DB; Dwosh HA; Walmsley SL; Mazzulli T; Avendano M; Derkach P; Ephtimios IE; Kitai I; Mederski BD; Shadowitz SB; Gold WL; Hawryluck LA; Rea E; Chenkin JS; Cescon DW; Poutanen SM; Detsky AS
JAMA; 2003 Jun; 289(21):2801-9. PubMed ID: 12734147
[TBL] [Abstract][Full Text] [Related]
6. Clinical trials and novel pathogens: lessons learned from SARS.
Muller MP; McGeer A; Straus SE; Hawryluck L; Gold WL
Emerg Infect Dis; 2004 Mar; 10(3):389-94. PubMed ID: 15109402
[TBL] [Abstract][Full Text] [Related]
7. Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1.
Sievert W; Dore GJ; McCaughan GW; Yoshihara M; Crawford DH; Cheng W; Weltman M; Rawlinson W; Rizkalla B; Depamphilis JK; Roberts SK;
Hepatology; 2011 Apr; 53(4):1109-17. PubMed ID: 21480317
[TBL] [Abstract][Full Text] [Related]
8. Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003.
Leong HN; Ang B; Earnest A; Teoh C; Xu W; Leo YS
Trop Med Int Health; 2004 Aug; 9(8):923-7. PubMed ID: 15303999
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics, management and prognostic factors in patients with probable severe acute respiratory syndrome (SARS) in a SARS center in Taiwan.
Liu CY; Huang LJ; Lai CH; Chen HP; Chen TL; Fung CP; Liu CY
J Chin Med Assoc; 2005 Mar; 68(3):110-7. PubMed ID: 15813244
[TBL] [Abstract][Full Text] [Related]
10. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.
Chu CM; Cheng VC; Hung IF; Wong MM; Chan KH; Chan KS; Kao RY; Poon LL; Wong CL; Guan Y; Peiris JS; Yuen KY;
Thorax; 2004 Mar; 59(3):252-6. PubMed ID: 14985565
[TBL] [Abstract][Full Text] [Related]
11. Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol.
Lau AC; So LK; Miu FP; Yung RW; Poon E; Cheung TM; Yam LY
Respirology; 2004 Jun; 9(2):173-83. PubMed ID: 15182266
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and pharmacotherapy of severe acute respiratory syndrome: what have we learnt?
Tsang KW; Ooi GC; Ho PL
Eur Respir J; 2004 Dec; 24(6):1025-32. PubMed ID: 15572549
[TBL] [Abstract][Full Text] [Related]
13. Antiviral treatment of SARS: can we draw any conclusions?
Zhaori G
CMAJ; 2003 Nov; 169(11):1165-6. PubMed ID: 14638651
[No Abstract] [Full Text] [Related]
14. The war against an unknown pathogen: rising to the SARS challenge.
Can Commun Dis Rep; 2003 May; 29(9):77-82. PubMed ID: 12739275
[No Abstract] [Full Text] [Related]
15. Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
Liu CH; Huang CF; Liu CJ; Dai CY; Liang CC; Huang JF; Hung PH; Tsai HB; Tsai MK; Chen SI; Lin JW; Yang SS; Su TH; Yang HC; Chen PJ; Chen DS; Chuang WL; Yu ML; Kao JH
Ann Intern Med; 2013 Dec; 159(11):729-38. PubMed ID: 24297189
[TBL] [Abstract][Full Text] [Related]
16. Anemia associated with antiviral therapy in chronic hepatitis C: incidence, risk factors, and impact on treatment response.
Hung CH; Lee CM; Lu SN; Wang JH; Chen CH; Hu TH; Kee KM; Chang KC; Tseng PL; Yen YH; Changchien CS
Liver Int; 2006 Nov; 26(9):1079-86. PubMed ID: 17032408
[TBL] [Abstract][Full Text] [Related]
17. Infectious diseases. Battling SARS on the frontlines.
Normile D
Science; 2003 May; 300(5620):714-5. PubMed ID: 12730562
[No Abstract] [Full Text] [Related]
18. Common genetic polymorphism of ITPA gene affects ribavirin-induced anemia and effect of peg-interferon plus ribavirin therapy.
Azakami T; Hayes CN; Sezaki H; Kobayashi M; Akuta N; Suzuki F; Kumada H; Abe H; Miki D; Tsuge M; Imamura M; Kawakami Y; Takahashi S; Ochi H; Nakamura Y; Kamatani N; Chayama K
J Med Virol; 2011 Jun; 83(6):1048-57. PubMed ID: 21503919
[TBL] [Abstract][Full Text] [Related]
19. Severe acute respiratory syndrome.
Christian MD; Poutanen SM; Loutfy MR; Muller MP; Low DE
Clin Infect Dis; 2004 May; 38(10):1420-7. PubMed ID: 15156481
[TBL] [Abstract][Full Text] [Related]
20. A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan.
Wang YH; Lin AS; Chao TY; Lu SN; Liu JW; Chen SS; Lin MC
Intensive Care Med; 2004 Jun; 30(6):1228-31. PubMed ID: 15105985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
